Information on this page is only for patients prescribed Quinsair and their carers
Quinsair contains an antibiotic called levofloxacin which helps fight chest infections caused by Pseudomonas aeruginosa. Pseudomonas is a very common bacterium that infects nearly all patients with cystic fibrosis.1
In the video below, you will learn more about how CF affects the fluid that lines the airways and lungs. In patients with CF, there is a build-up of mucus in the airways which is thick and sticky. This traps germs which can lead to an infection. Antibiotics like Quinsair work to fight the germs that cause infection.
Quinsair is inhaled through a nebuliser on a daily basis. You should inhale the contents of one ampoule in the morning and one in the evening.1 Doses should be inhaled close to 12 hours apart. Inhaling Quinsair at the same time each day will help you remember when to take your medicine. The recommended course of treatment is to use Quinsair every day for 28 days, then take a 28-day break, during which you do not take Quinsair. You then start another treatment course.1 Keep taking Quinsair in this way until your healthcare professional tells you to stop. Always use this medicine exactly as your healthcare professional has told you. Check with your healthcare professional or pharmacist if you are not sure.
Quinsair does not require any special temperature storage conditions.1 You should store it in the original package, in order to protect it from light.
For a full list of side effects, please see the Quinsair patient information leaflet which can be found inside your Quinsair packaging.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects in the UK or www.hpra.ie for Ireland.
1. Quinsair, Patient Leaflet, December 2016, Chiesi Limited
This website has been provided by Chiesi Limited to support patients, and carers of patients, prescribed Chiesi CF products.